Brief: Cerus Announces US FDA Approval Of Extended Shelf Life For INTERCEPT Platelet Processing Sets
26/03/2024 13:45
March 26 (Reuters) - Cerus Corp CERS.O :
* CERUS CORPORATION ANNOUNCES FDA APPROVAL OF EXTENDED SHELF
LIFE
FOR INTERCEPT PLATELET PROCESSING SETS – DOUBLING PREVIOUS SHELF
LIFE
* CERUS: CONTINUING TO GENERATE MORE DATA TO PURSUE
POTENTIAL
SHELF LIFE EXTENSION FROM FDA BEYOND 12 MONTHS FOR INTERCEPT
PLATELET PROCESSING SETS
* CERUS CORP: FDA GRANTED APPROVAL OF 12-MONTH SHELF LIFE
FOR
INTERCEPT PLATELET PROCESSING SETS
Source text for Eikon: ID:nBw2hVVYFa
Further company coverage: CERS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cerus
See all newsCerus Corp reports results for the quarter ended June 30 - Earnings Summary
Cerus Q2 adjusted EBITDA misses estimates, raises 2026 outlook
Brief: Cerus Q2 Gross Profit USD 29.5 Million
Cerus Corp expected to post a loss of 1 cent a share - Earnings Preview
Brief: Cerus Corporation Closes New Debt Facility Of Up To $110 Million